retatrutide on the market UK 2026: Phase 3 Results Retatrutide, a new weight loss

Americas healthcare is a tale of two systems: one elite, proactive tier for the wealthy, and a broken, reactive one for everyone else, Kenger said

GLP-1 drugs may reshape brain's dopamine reward system Beyond weight loss, research is pointing to broader effects on the brain

When you submit ideas, documents, suggestions and/or proposals ("Contributions") to our site, you acknowledge and agree that: a) your contributions do not contain any type of confidential or proprietary information

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity